Covid-19 Vaccine: UK Experts Caution Against Hopes Of ‘Return To Normal’

Distribution of Pfizer/BioNTech Vaccine Will Be A ‘Mammoth’ Logistical Operation

The Pfizer/BioNTech coronavirus vaccine results are a cause for celebration, but there is still a long way to go. Safety data are still awaited, as is more information on efficacy, and the mass rollout of the vaccine will pose significant practical challenges.

Back to normal. Hand turns dice and changes the expression "corona life" to "normal life".
What will the post-COVID-19 normal look like? • Source: Shutterstock

UK politicians and health experts have welcomed the interim trial results for the Pfizer/BioNTech COVID-19 vaccine candidate but they are counseling caution and playing down suggestions that “things could return to normal” by spring 2021.

The results showed the vaccine had an efficacy rate of more than 90%. Health Secretary Matt Hancock described the news...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

UK HRA Sets Targets For Digital Overhaul, Trial Transparency And Trust

 
• By 

The UK Health Research Authority’s latest three-year strategy sets ambitious targets to make research more transparent. One World Health Organization official believes the authority can go further by setting equally high standards for the timely reporting of clinical trial results.

UK’s Plan To Become World’s Third Top Life Sciences Economy Falls Short, Says ABPI

 

The Association of the British Pharmaceutical Industry says that while the government’s newly published Life Sciences Sector Plan includes many positive commitments, they are not enough.

England Leads Europe In Reimbursing Vertex’s Next-In-Class CF Drug Alyftrek

 

Vertex said it reached “a broad reimbursement agreement” with the National Health Service for its once-daily, triple combination treatment for cystic fibrosis. As for reimbursement in the rest of Europe, the company is targeting Ireland, Denmark and Germany next.

UK HRA Working On ‘Trusted’ Path Forward To Support Simplified Informed Consent

 
• By 

The Health Research Authority is working on a streamlined model for informed consent that maintains people’s trust.

More from Europe